Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org of the Federal Food, Drug, and Cosmetic Act (FDCA).* BPC 157: Miracle Healing Peptide or Hidden Danger?